Fund profile
Fund manager
Total assets
$187.76 mm
Liabilities
$2.67 mm
Net assets
$185.08 mm
Number of holdings
177.00
177 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
LLY Eli Lilly and Company | 22.42 mm | 24.76 k shares | 12.11 | Common equity | Long | USA |
UNH UnitedHealth Group Incorporated | 12.04 mm | 23.64 k shares | 6.50 | Common equity | Long | USA |
ISRG Intuitive Surgical, Inc. | 8.88 mm | 19.97 k shares | 4.80 | Common equity | Long | USA |
TMO Thermo Fisher Scientific Inc. | 8.25 mm | 14.92 k shares | 4.46 | Common equity | Long | USA |
MRK Merck & Co., Inc. | 7.33 mm | 59.18 k shares | 3.96 | Common equity | Long | USA |
ELV Elevance Health Inc. | 6.99 mm | 12.90 k shares | 3.78 | Common equity | Long | USA |
SYK Stryker Corporation | 6.63 mm | 19.48 k shares | 3.58 | Common equity | Long | USA |
DHR Danaher Corporation | 6.30 mm | 25.22 k shares | 3.40 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 5.86 mm | 5.57 k shares | 3.17 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 4.79 mm | 10.23 k shares | 2.59 | Common equity | Long | USA |
AstraZeneca plc
|
4.76 mm | 61.05 k shares | 2.57 | Common equity | Long | UK |
AMGN Amgen Inc. | 4.37 mm | 13.99 k shares | 2.36 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 4.11 mm | 16.93 k shares | 2.22 | Common equity | Long | USA |
ARGX argenx SE | 4.01 mm | 9.33 k shares | 2.17 | Common equity | Long | Netherlands |
NVO Novo Nordisk A/S | 3.22 mm | 22.53 k shares | 1.74 | Common equity | Long | Denmark |
Cigna Holding Co | 3.20 mm | 9.67 k shares | 1.73 | Common equity | Long | USA |
BSX Boston Scientific Corporation | 2.93 mm | 38.02 k shares | 1.58 | Common equity | Long | USA |
EW Edwards Lifesciences Corporation | 2.53 mm | 27.39 k shares | 1.37 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 2.48 mm | 23.02 k shares | 1.34 | Common equity | Long | USA |
INSM Insmed Incorporated | 2.25 mm | 33.60 k shares | 1.22 | Common equity | Long | USA |
BDX Becton, Dickinson and Company | 2.04 mm | 8.71 k shares | 1.10 | Common equity | Long | USA |
HCA HCA Healthcare, Inc. | 2.03 mm | 6.32 k shares | 1.10 | Common equity | Long | USA |
MOH Molina Healthcare, Inc. | 1.94 mm | 6.54 k shares | 1.05 | Common equity | Long | USA |
INVESCO GOVERNMENT & AGENCY PORTFOLIO OPEN-END FUND USD | 1.76 mm | 1.76 mm principal | 0.95 | Short-term investment vehicle | Long | USA |
PEN Penumbra, Inc. | 1.71 mm | 9.52 k shares | 0.93 | Common equity | Long | USA |
RNA Avidity Biosciences, Inc. | 1.63 mm | 39.88 k shares | 0.88 | Common equity | Long | USA |
THC Tenet Healthcare Corporation | 1.47 mm | 11.04 k shares | 0.79 | Common equity | Long | USA |
A Agilent Technologies, Inc. | 1.40 mm | 10.77 k shares | 0.75 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 1.36 mm | 9.90 k shares | 0.74 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals, Inc. | 1.23 mm | 4.39 k shares | 0.66 | Common equity | Long | USA |
BeiGene Ltd.
|
1.21 mm | 8.47 k shares | 0.65 | Common equity | Long | Cayman Islands |
ICON plc
|
1.15 mm | 3.66 k shares | 0.62 | Common equity | Long | Ireland |
HUM Humana Inc. | 1.13 mm | 3.01 k shares | 0.61 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 1.09 mm | 7.96 k shares | 0.59 | Common equity | Long | Denmark |
TECH Bio-Techne Corporation | 1.04 mm | 14.45 k shares | 0.56 | Common equity | Long | USA |
DXCM DexCom, Inc. | 1.00 mm | 8.86 k shares | 0.54 | Common equity | Long | USA |
KRYS Krystal Biotech, Inc. | 868.62 k | 4.73 k shares | 0.47 | Common equity | Long | USA |
HOLX Hologic, Inc. | 864.05 k | 11.64 k shares | 0.47 | Common equity | Long | USA |
MCK McKesson Corporation | 859.12 k | 1.47 k shares | 0.46 | Common equity | Long | USA |
BIIB Biogen Inc. | 819.25 k | 3.53 k shares | 0.44 | Common equity | Long | USA |
Biohaven Ltd.
|
793.96 k | 22.87 k shares | 0.43 | Common equity | Long | Virgin Islands (British) |
PCVX Vaxcyte, Inc. | 792.55 k | 10.50 k shares | 0.43 | Common equity | Long | USA |
BMRN BioMarin Pharmaceutical Inc. | 767.81 k | 9.33 k shares | 0.41 | Common equity | Long | USA |
RVMD Revolution Medicines, Inc. | 764.67 k | 19.70 k shares | 0.41 | Common equity | Long | USA |
MLTX MoonLake Immunotherapeutics | 708.22 k | 16.11 k shares | 0.38 | Common equity | Long | Cayman Islands |
CNC Centene Corporation | 700.13 k | 10.56 k shares | 0.38 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals, Inc. | 679.01 k | 15.75 k shares | 0.37 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals, Inc. | 616.20 k | 12.93 k shares | 0.33 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals, Inc. | 616.13 k | 13.76 k shares | 0.33 | Common equity | Long | USA |
CLDX Celldex Therapeutics, Inc. | 607.30 k | 16.41 k shares | 0.33 | Common equity | Long | USA |
DREYFUS TREASURY OBLIGATIONS CASH MANAGEMENT FUND OPEN-END FUND USD | 600.00 k | 600.00 k principal | 0.32 | Short-term investment vehicle | Long | USA |
Merus NV
|
591.58 k | 10.00 k shares | 0.32 | Common equity | Long | Netherlands |
GPCR Structure Therapeutics Inc. | 584.69 k | 14.89 k shares | 0.32 | Common equity | Long | Cayman Islands |
UTHR United Therapeutics Corporation | 573.39 k | 1.80 k shares | 0.31 | Common equity | Long | USA |
Chugai Pharmaceutical Co. Ltd.
|
568.44 k | 16.00 k shares | 0.31 | Common equity | Long | Japan |
IMCR Immunocore Holdings plc | 568.17 k | 16.77 k shares | 0.31 | Common equity | Long | UK |
RARE Ultragenyx Pharmaceutical Inc. | 549.22 k | 13.36 k shares | 0.30 | Common equity | Long | USA |
LEGN Legend Biotech Corporation | 545.92 k | 12.33 k shares | 0.29 | Common equity | Long | Cayman Islands |
CAH Cardinal Health, Inc. | 544.99 k | 5.54 k shares | 0.29 | Common equity | Long | USA |
IDXX IDEXX Laboratories, Inc. | 525.69 k | 1.08 k shares | 0.28 | Common equity | Long | USA |
OSCR Oscar Health, Inc. | 517.25 k | 32.70 k shares | 0.28 | Common equity | Long | USA |
KYMR Kymera Therapeutics, Inc. | 512.38 k | 17.17 k shares | 0.28 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics, Inc. | 500.11 k | 13.28 k shares | 0.27 | Common equity | Long | USA |
PODD Insulet Corporation | 484.93 k | 2.40 k shares | 0.26 | Common equity | Long | USA |
Daiichi Sankyo Co. Ltd.
|
466.94 k | 13.60 k shares | 0.25 | Common equity | Long | Japan |
Alkermes plc
|
459.11 k | 19.05 k shares | 0.25 | Common equity | Long | Ireland |
RVTY Revvity, Inc. | 440.41 k | 4.20 k shares | 0.24 | Common equity | Long | USA |
RGEN Repligen Corporation | 440.33 k | 3.49 k shares | 0.24 | Common equity | Long | USA |
EXAS Exact Sciences Corporation | 432.56 k | 10.24 k shares | 0.23 | Common equity | Long | USA |
CRGX CARGO Therapeutics, Inc. Common Stock | 431.67 k | 26.29 k shares | 0.23 | Common equity | Long | USA |
VERA Vera Therapeutics, Inc. | 427.29 k | 11.81 k shares | 0.23 | Common equity | Long | USA |
LBPH Longboard Pharmaceuticals, Inc. | 424.32 k | 15.70 k shares | 0.23 | Common equity | Long | USA |
ACLX Arcellx, Inc. | 419.00 k | 7.59 k shares | 0.23 | Common equity | Long | USA |
TXG 10x Genomics, Inc. | 407.19 k | 20.94 k shares | 0.22 | Common equity | Long | USA |
Novocure Ltd.
|
404.59 k | 23.62 k shares | 0.22 | Common equity | Long | Jersey |
COR Cencora | 395.18 k | 1.75 k shares | 0.21 | Common equity | Long | USA |
PTGX Protagonist Therapeutics, Inc. | 391.55 k | 11.30 k shares | 0.21 | Common equity | Long | USA |
DYN Dyne Therapeutics, Inc. | 391.26 k | 11.09 k shares | 0.21 | Common equity | Long | USA |
IDYA IDEAYA Biosciences, Inc. | 391.16 k | 11.14 k shares | 0.21 | Common equity | Long | USA |
Sonova Holding AG (Registered)
|
389.93 k | 1.26 k shares | 0.21 | Common equity | Long | Switzerland |
PRCT PROCEPT BioRobotics Corporation | 382.67 k | 6.26 k shares | 0.21 | Common equity | Long | USA |
GERN Geron Corporation | 370.84 k | 87.46 k shares | 0.20 | Common equity | Long | USA |
APGE Apogee Therapeutics, Inc. | 364.22 k | 9.26 k shares | 0.20 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc. | 360.26 k | 15.38 k shares | 0.19 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc. | 360.03 k | 15.51 k shares | 0.19 | Common equity | Long | USA |
Sartorius AG (Preference)
|
349.70 k | 1.49 k shares | 0.19 | Common equity | Long | Germany |
CYTK Cytokinetics, Incorporated | 339.22 k | 6.26 k shares | 0.18 | Common equity | Long | USA |
MORF Morphic Holding, Inc. | 335.52 k | 9.85 k shares | 0.18 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals, Inc. | 333.99 k | 15.51 k shares | 0.18 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals, Inc. | 332.39 k | 8.67 k shares | 0.18 | Common equity | Long | USA |
BCYC Bicycle Therapeutics plc | 331.98 k | 16.40 k shares | 0.18 | Common equity | Long | UK |
INSP Inspire Medical Systems, Inc. | 330.83 k | 2.47 k shares | 0.18 | Common equity | Long | USA |
LNTH Lantheus Holdings, Inc. | 328.55 k | 4.09 k shares | 0.18 | Common equity | Long | USA |
Zai Lab Ltd.
|
312.98 k | 18.06 k shares | 0.17 | Common equity | Long | Cayman Islands |
BRKR Bruker Corporation | 306.10 k | 4.80 k shares | 0.17 | Common equity | Long | USA |
RAPP Rapport Therapeutics, Inc. Common Stock | 305.26 k | 13.12 k shares | 0.16 | Common equity | Long | USA |
Immatics NV
|
277.04 k | 23.84 k shares | 0.15 | Common equity | Long | Netherlands |
CGON CG Oncology, Inc. Common stock | 275.16 k | 8.72 k shares | 0.15 | Common equity | Long | USA |
Siemens Healthineers AG
|
273.45 k | 4.75 k shares | 0.15 | Common equity | Long | Germany |
ARVN Arvinas, Inc. | 272.24 k | 10.23 k shares | 0.15 | Common equity | Long | USA |
XNCR Xencor, Inc. | 259.45 k | 13.71 k shares | 0.14 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics, Inc. | 256.41 k | 31.97 k shares | 0.14 | Common equity | Long | USA |
AKRO Akero Therapeutics, Inc. | 254.92 k | 10.87 k shares | 0.14 | Common equity | Long | USA |
SRPT Sarepta Therapeutics, Inc. | 251.85 k | 1.59 k shares | 0.14 | Common equity | Long | USA |
IMNM Immunome, Inc. | 240.37 k | 19.87 k shares | 0.13 | Common equity | Long | USA |
ELAN Elanco Animal Health Incorporated | 238.10 k | 16.50 k shares | 0.13 | Common equity | Long | USA |
CNTA Centessa Pharmaceuticals plc | 234.26 k | 25.94 k shares | 0.13 | Common equity | Long | UK |
MRNA Moderna, Inc. | 229.43 k | 1.93 k shares | 0.12 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corporation | 227.51 k | 27.31 k shares | 0.12 | Common equity | Long | USA |
ARDX Ardelyx, Inc. | 212.87 k | 28.73 k shares | 0.12 | Common equity | Long | USA |
SANA Sana Biotechnology, Inc. | 211.60 k | 38.76 k shares | 0.11 | Common equity | Long | USA |
Prothena Corp. plc
|
204.65 k | 9.92 k shares | 0.11 | Common equity | Long | Ireland |
SLNO Soleno Therapeutics, Inc. | 194.58 k | 4.77 k shares | 0.11 | Common equity | Long | USA |
PRAX Praxis Precision Medicines, Inc. | 193.73 k | 4.68 k shares | 0.10 | Common equity | Long | USA |
SMMT Summit Therapeutics Inc. | 189.54 k | 24.30 k shares | 0.10 | Common equity | Long | USA |
Pharvaris NV
|
189.05 k | 10.06 k shares | 0.10 | Common equity | Long | Netherlands |
BTSG BrightSpring Health Services, Inc. Common Stock | 175.65 k | 15.46 k shares | 0.09 | Common equity | Long | USA |
Tempus AI, Inc., Class A
|
171.08 k | 4.89 k shares | 0.09 | Common equity | Long | USA |
RLAY Relay Therapeutics, Inc. | 170.77 k | 26.19 k shares | 0.09 | Common equity | Long | USA |
REPL Replimune Group, Inc. | 170.33 k | 18.93 k shares | 0.09 | Common equity | Long | USA |
ALLO Allogene Therapeutics, Inc. | 165.62 k | 71.08 k shares | 0.09 | Common equity | Long | USA |
GH Guardant Health, Inc. | 164.13 k | 5.68 k shares | 0.09 | Common equity | Long | USA |
SGRY Surgery Partners, Inc. | 147.33 k | 6.19 k shares | 0.08 | Common equity | Long | USA |
IRON Disc Medicine, Inc. | 145.67 k | 3.23 k shares | 0.08 | Common equity | Long | USA |
CRBP Corbus Pharmaceuticals Holdings, Inc. | 135.75 k | 3.00 k shares | 0.07 | Common equity | Long | USA |
LYEL Lyell Immunopharma, Inc. | 135.68 k | 93.57 k shares | 0.07 | Common equity | Long | USA |
Verona Pharma plc
|
134.48 k | 9.30 k shares | 0.07 | Common equity | Long | UK |
RYTM Rhythm Pharmaceuticals, Inc. | 132.91 k | 3.24 k shares | 0.07 | Common equity | Long | USA |
AGL agilon health, inc. | 128.25 k | 19.61 k shares | 0.07 | Common equity | Long | USA |
ENOV Enovis Corporation | 126.56 k | 2.80 k shares | 0.07 | Common equity | Long | USA |
ACAD ACADIA Pharmaceuticals Inc. | 122.88 k | 7.56 k shares | 0.07 | Common equity | Long | USA |
WaVe Life Sciences Ltd.
|
120.90 k | 24.23 k shares | 0.07 | Common equity | Long | Singapore |
Helix Acquisition Corp. II, Class A
|
114.39 k | 11.19 k shares | 0.06 | Common equity | Long | Cayman Islands |
PLRX Pliant Therapeutics, Inc. | 113.09 k | 10.52 k shares | 0.06 | Common equity | Long | USA |
NMRA Neumora Therapeutics, Inc. Common Stock | 113.05 k | 11.50 k shares | 0.06 | Common equity | Long | USA |
VYGR Voyager Therapeutics, Inc. | 112.06 k | 14.17 k shares | 0.06 | Common equity | Long | USA |
BCRX BioCryst Pharmaceuticals, Inc. | 111.86 k | 18.10 k shares | 0.06 | Common equity | Long | USA |
ORIC ORIC Pharmaceuticals, Inc. | 111.00 k | 15.70 k shares | 0.06 | Common equity | Long | USA |
NTRA Natera, Inc. | 108.29 k | 1.00 k shares | 0.06 | Common equity | Long | USA |
SAGE Sage Therapeutics, Inc. | 105.77 k | 9.74 k shares | 0.06 | Common equity | Long | USA |
SYRE Spyre Therapeutics, Inc. | 102.22 k | 4.35 k shares | 0.06 | Common equity | Long | USA |
EYPT EyePoint Pharmaceuticals, Inc. | 96.65 k | 11.11 k shares | 0.05 | Common equity | Long | USA |
Sensorion SA
|
96.26 k | 125.89 k shares | 0.05 | Common equity | Long | France |
TARS Tarsus Pharmaceuticals, Inc. | 95.05 k | 3.50 k shares | 0.05 | Common equity | Long | USA |
TRDA Entrada Therapeutics, Inc. | 94.98 k | 6.67 k shares | 0.05 | Common equity | Long | USA |
Autolus Therapeutics plc
|
86.69 k | 24.91 k shares | 0.05 | Common equity | Long | UK |
GBIO Generation Bio Co. | 84.99 k | 30.14 k shares | 0.05 | Common equity | Long | USA |
JANX Janux Therapeutics, Inc. | 83.78 k | 2.00 k shares | 0.05 | Common equity | Long | USA |
GLUE Monte Rosa Therapeutics, Inc. | 83.71 k | 22.38 k shares | 0.05 | Common equity | Long | USA |
IGMS IGM Biosciences, Inc. | 83.56 k | 12.16 k shares | 0.05 | Common equity | Long | USA |
ANAB AnaptysBio, Inc. | 77.69 k | 3.10 k shares | 0.04 | Common equity | Long | USA |
ZNTL Zentalis Pharmaceuticals, Inc. | 75.28 k | 18.41 k shares | 0.04 | Common equity | Long | USA |
ANNX Annexon, Inc. | 74.58 k | 15.22 k shares | 0.04 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals, Inc. | 73.93 k | 5.37 k shares | 0.04 | Common equity | Long | USA |
OBIO Orchestra BioMed Holdings, Inc. | 73.72 k | 9.05 k shares | 0.04 | Common equity | Long | USA |
Pharming Group NV
|
71.55 k | 88.79 k shares | 0.04 | Common equity | Long | Netherlands |
OCUL Ocular Therapeutix, Inc. | 71.14 k | 10.40 k shares | 0.04 | Common equity | Long | USA |
ANRO Alto Neuroscience, Inc. | 66.18 k | 6.19 k shares | 0.04 | Common equity | Long | USA |
MGNX MacroGenics, Inc. | 63.33 k | 14.90 k shares | 0.03 | Common equity | Long | USA |
ALEC Alector, Inc. | 58.36 k | 12.85 k shares | 0.03 | Common equity | Long | USA |
AURA Aura Biosciences, Inc. | 55.17 k | 7.30 k shares | 0.03 | Common equity | Long | USA |
KYTX Kyverna Therapeutics, Inc. Common Stock | 49.18 k | 6.56 k shares | 0.03 | Common equity | Long | USA |
CABA Cabaletta Bio, Inc. | 47.87 k | 6.40 k shares | 0.03 | Common equity | Long | USA |
GOSS Gossamer Bio, Inc. | 47.44 k | 52.66 k shares | 0.03 | Common equity | Long | USA |
PRLD Prelude Therapeutics Incorporated | 39.04 k | 10.25 k shares | 0.02 | Common equity | Long | USA |
BDTX Black Diamond Therapeutics, Inc. | 36.35 k | 7.80 k shares | 0.02 | Common equity | Long | USA |
NxStage Medical, Inc. | 34.98 k | 25.53 k shares | 0.02 | Common equity | Long | USA |
IMRX Immuneering Corporation | 28.84 k | 22.53 k shares | 0.02 | Common equity | Long | USA |
HIMS Hims & Hers Health, Inc. | 28.27 k | 1.40 k shares | 0.02 | Common equity | Long | USA |
TSHA Taysha Gene Therapies, Inc. | 27.55 k | 12.30 k shares | 0.01 | Common equity | Long | USA |
ABOS Acumen Pharmaceuticals, Inc. | 25.89 k | 10.70 k shares | 0.01 | Common equity | Long | USA |
WGS GeneDx Holdings Corp. | 19.45 k | 744.00 shares | 0.01 | Common equity | Long | USA |
DNA Ginkgo Bioworks Holdings, Inc. | 18.01 k | 53.86 k shares | 0.01 | Common equity | Long | USA |
RAPT RAPT Therapeutics, Inc. | 9.07 k | 2.97 k shares | 0.00 | Common equity | Long | USA |
RVMD Revolution Medicines, Inc. | 222.96 | 3.13 k shares | 0.00 | DO | N/A | USA |
WGS GeneDx Holdings Corp. | 98.96 | 3.33 k shares | 0.00 | DO | N/A | USA |
SLGCW SomaLogic, Inc. | 0 | 1.42 k shares | 0.00 | DO | N/A | USA |